Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Ming Capital Leads $33 Million Round in Belgium's Miracor Medical

publication date: Sep 5, 2018

Ming Capital of Shenzhen led a $33 million Series D round in Belgium's Miracor Medical SA, a medical device maker. Miracor will use the capital to continue developing its PiCSO® Impulse System, an interventional cardiology device used to improve perfusion following an acute myocardial infarction. Miracor focuses on devices that treat cardiac disease. Ming Capital was joined by an unnamed strategic investor who co-led the round along with investors Quest for Growth of Belgium, SFPI and Meusinvest. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital